Charles Ruban serves as DBV’s Chief Operating Officer, overseeing Commercial Operations globally and responsible for aligning all Regulatory, Development and Manufacturing. He is a member of the Executive Committee. Mr. Ruban joined DBV in 2012 as Chief Development Officer to lead all development activities; subsequently he was appointed President, North America and Chief Commercial Officer, overseeing North American Operations and supporting the US launch of Viaskin Peanut. Prior to DBV, from 2003 to 2012, he held various executive positions at Stallergenes S.A., including Senior Vice President of Product Development. From 1994 to 2003, Mr. Ruban spent nine years at Eurogroup Consulting as a management and strategy consultant for international industrial clients, including healthcare companies. Mr. Ruban received an Engineering degree from the École Centrale de Lyon, trained at Harvard-MIT Division of Health Sciences and Technology for his Biomedical Engineering Master of Science, and received an Executive MBA from INSEAD.